Article contents
The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study
Published online by Cambridge University Press: 22 August 2022
Abstract
In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Li, J, Wang, J, Yang, Y, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control 2020;9:153.10.1186/s13756-020-00819-1CrossRefGoogle ScholarPubMed
Calderón-Parra, J, Muiño-Miguez, A, Bendala-Estrada, AD, et al. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One 2021;16:e0251340.10.1371/journal.pone.0251340CrossRefGoogle ScholarPubMed
Arastehfar, A, Carvalho, A, van de Veerdonk, FL, et al. COVID-19–associated pulmonary aspergillosis (CAPA)—from immunology to treatment. J Fungi (Basel) 2020;6:91.10.3390/jof6020091CrossRefGoogle ScholarPubMed
Peters, C, Williams, K, Un, EA, et al. Use of procalcitonin for antibiotic stewardship in patients with COVID-19: a quality improvement project in a district general hospital. Clin Med (Lond) 2021;21:71–76.10.7861/clinmed.2020-0614CrossRefGoogle Scholar
Sathitakorn, O, Jantarathaneewat, K, Weber, DJ, et al. The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe–critically ill COVID-19 pneumonia patients: a pilot study. Am J Infect Control 2022;50:581–584.10.1016/j.ajic.2022.01.030CrossRefGoogle ScholarPubMed
Schurink, CAM. Clinical pulmonary infection score (CPIS) for ventilator-associated pneumonia (VAP). MD+CALC website. https://www.mdcalc.com/clinical-pulmonary-infection-score-cpis-ventilator-associated-pneumonia-vap. Published 2020. Accessed January 1, 2021Google Scholar
Kunin, CM, Tupasi, T, Craig, WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79:555–560.10.7326/0003-4819-79-4-555CrossRefGoogle ScholarPubMed
Lee, CC, Kwa, ALH, Apisarnthanarak, A, et al. Procalcitonin (PCT)-guided antibiotic stewardship in Asian-Pacific countries: adaptation based on an expert consensus meeting. Clin Chem Lab Med 2020;58:1983–1991.10.1515/cclm-2019-1122CrossRefGoogle Scholar
Wei, PF. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin Med J (Engl) 2020;133:1087–1095.Google Scholar
Singh, N, Rogers, P, Atwood, CW, Wagener, MM, Yu, VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.10.1164/ajrccm.162.2.9909095CrossRefGoogle ScholarPubMed
- 2
- Cited by